Skip to content

Actuate Therapeutics, Inc.

ACTU· NasdaqCore metricsCIK 1652935

Pharmaceutical preparations553 peers

Last sale
Nov 12, 2026 · -2.52%
Market cap
$7.38M
24.75M shares
Filings
193
—
—
—
-$3.42M
Q3 2026N/M FY25 yoy
-$3.44M
Q3 2026N/M FY25 yoy
—
—
—
-$0.14
Q3 2026N/M FY25 yoy
$2.10M
Q3 2026+52.3% FY25 yoy
$7.38M
—
—
—
—
—

FY2025 figures · derived

Price

$0.298195.16%$5.8669past year
Nov 12, 2026 · IEX last sale
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Research And Development

$10.29MFY 2025
$21.71M0FY 2023FY 2024FY 2025
PeriodEndedValueKindSource trail
FY 20252025-12-31$10,292,620reported
FY 20242024-12-31$18,676,276reported
FY 20232023-12-31$21,708,332reported

Pharmaceutical preparations

Actuate Therapeutics, Inc. is the 439th largest of the 554 covered companies the SEC files under this code, by market cap. SIC 2834

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in market cap first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

Actuate Therapeutics, Inc. · CIK 1652935 · Engraved from SEC EDGAR